These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33074049)

  • 21. Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs.
    Rodrigues L; Cravo P; Viveiros M
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):741-757. PubMed ID: 32434397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products.
    Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E
    Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of
    Kumar P; Saumya KU; Giri R
    J Biomol Struct Dyn; 2020 Oct; 38(17):4997-5013. PubMed ID: 31755364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual Docking Screening of Designed Hypothetical Inhibitors Against DNA gyrase Protein.
    Adeniji SE
    Curr Comput Aided Drug Des; 2021; 17(6):739-758. PubMed ID: 32586260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
    Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of inhibitors against Mycobacterium tuberculosis thiamin phosphate synthase, an important target for the development of anti-TB drugs.
    Khare G; Kar R; Tyagi AK
    PLoS One; 2011; 6(7):e22441. PubMed ID: 21818324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening.
    Pandey P; Chatterjee S; Berida T; Doerksen RJ; Roy S
    J Biomol Struct Dyn; 2022 Jul; 40(11):4832-4849. PubMed ID: 33353500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular insights of hyaluronic acid - ethambutol and hyaluronic acid - isoniazid drug conjugates act as promising novel drugs for the treatment of tuberculosis.
    Thirumalaisamy R; Aroulmoji V; Iqbal MN; Saride S; Bhuvaneswari M; Deepa M; Sivasankar C; Khan R
    J Biomol Struct Dyn; 2023 May; 41(8):3562-3573. PubMed ID: 35293842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
    Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments.
    Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM
    J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents.
    Yalcin-Ozkat G; Ersan RH; Ulger M; Ulger ST; Burmaoglu S; Yildiz I; Algul O
    J Biomol Struct Dyn; 2023 Apr; 41(7):2667-2686. PubMed ID: 35132948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis.
    Altharawi A; Alossaimi MA; Alanazi MM; Alqahatani SM; Tahir Ul Qamar M
    Sci Rep; 2023 Apr; 13(1):7014. PubMed ID: 37117557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
    Machado D; Couto I; Perdigão J; Rodrigues L; Portugal I; Baptista P; Veigas B; Amaral L; Viveiros M
    PLoS One; 2012; 7(4):e34538. PubMed ID: 22493700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational discovery of potent drugs to improve the treatment of pyrazinamide resistant Mycobacterium tuberculosis mutants.
    Jagadeb M; Rath SN; Sonawane A
    J Cell Biochem; 2018 Sep; 119(9):7328-7338. PubMed ID: 29761826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of novel quinoline-aminopiperidine derivatives as
    Wang J; Zhao C; Tu J; Yang H; Zhang X; Lv W; Zhai H
    J Biomol Struct Dyn; 2019 Jul; 37(11):2913-2925. PubMed ID: 30044186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico and in vitro study of Mycobacterium tuberculosis H37Rv uncharacterized protein (RipD): an insight on tuberculosis therapeutics.
    Arega AM; Dhal AK; Nayak S; Mahapatra RK
    J Mol Model; 2022 May; 28(6):171. PubMed ID: 35624324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Docking Suggests the Targets of Anti-Mycobacterial Natural Products.
    Baptista R; Bhowmick S; Shen J; Mur LAJ
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33477495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of First-Line Drug Resistance Mutations and Drug-Protein Interaction Dynamics from Tuberculosis Patients in South India.
    Nachappa SA; Neelambike SM; Amruthavalli C; Ramachandra NB
    Microb Drug Resist; 2018 May; 24(4):377-385. PubMed ID: 28813625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.